The cytoarchitectonically-uniform dorsal lateral geniculate nucleus (dLGN) can be biochemically and anatomically subdivided in wild-type mice: The nucleusÕ dorsolateral ÔshellÕ region contains the majority of cells positive for the calcium-binding protein calbindin-D28k, and receives the strongest concentration of inputs from the superior colliculus. This subdivision remains normal in mice lacking the b2 subunit of the nicotinic acetylcholine receptor. Although in these animals the dLGN contains fewer calbindin-positive cells, those cells are predominantly situated in the dorsolateral portion of the nucleus, and this region remains preferentially targeted by the colliculogeniculate projection.
Introduction
In carnivores and primates, a major feature of the dorsal lateral geniculate nucleus (dLGN) is its division into biochemically-, anatomically-and functionally distinct subregions, a division which often, though not always, occurs on a laminar template (e.g. Casagrande, 1994; Sherman, 1985) . Although the mouse dLGN is not cytoarchitectonically laminated, it too is subdivided: Inputs from the two eyes occupy separate regions of the nucleus (Godement, Salaun, & Imbert, 1984) . This leaves open the distinct possibility that the mouse dLGN also processes other aspects of the visual world in parallel, in other ÔhiddenÕ laminae (Reese, 1988) . Indeed, numerous pieces of anatomical evidence suggest that such a hidden lamina exists in the dorsolateral region of the dLGN in the mouseÕs close rodent relative, the rat (Reese, 1988) .
Is the dorsolateral region of the mouse dLGN also different from the remainder of the nucleus? We investigate this question using two techniques that have demonstrated geniculate subdivision in other mammalian species. Immunocytochemical labelling of calcium-binding proteins has revealed distinct differences between separate laminae in the primate dLGN: Only neurons in the small-celled koniocellular layers contain calbindin-D28k, while parvalbumin-containing neurons are found in all other geniculate laminae (Diamond, Fitzpatrick, & Schmechel, 1993; Goodchild & Martin, 1998; Johnson & Casagrande, 1995; Jones & Hendry, 1989) . Similar biochemical distinctions in the carnivore, however, are far less clear-cut (Demeulemeester et al., 1991) . Subdivision by another feature is more conserved across mammalian species: Neuroanatomical tracing has revealed that the projection to the dLGN from the superior colliculus (SC) always terminates predominantly in small-celled regions of the nucleus, including the primate koniocellular layers and the C laminae in carnivores (Harting, Huerta, Hashikawa, & van Lieshout, 1991; Reese, 1984) . Employing immunohistochemical labelling of calcium-binding proteins and neuroanatomical tracing of the colliculogeniculate projection in the present study should reveal whether mouse dLGN is also subdivided according to these biochemical and anatomical features.
We also study biochemical and anatomical subdivision of the dLGN in mice lacking the b2 subunit of the nicotinic acetylcholine receptor (nAChR). The organisation of the dLGN in these animals is already known to be profoundly abnormal. In addition to deficits in fine retinotopy (Grubb, Rossi, Changeux, & Thompson, 2003) and anomalous organisation according to On-Off receptive field type , ocular organisation is severely disturbed in the b2À/À geniculate. Ocular segregation is normal, with individual geniculate cells receiving inputs from only one eye (Muir-Robinson, Hwang, & Feller, 2002; , but ocular ÔlaminationÕ does not occur; instead, ipsilateral inputs to the b 2À/À dLGN form a series of small isolated ÔislandsÕ surrounded by contralaterallyinnervated tissue (Rossi et al., 2001; Muir-Robinson et al., 2002) . Here we investigate whether these deficits in functional organisation, believed to be caused by abnormal patterns of spontaneous activity in the developing postnatal b2À/À retina (McLaughlin, Torborg, Feller, & OÕLeary, 2003) , are accompanied by additional abnormalities in ÔhiddenÕ biochemical or colliculogeniculate subdivision of the mouse dLGN.
Methods

Animals
Wild-type animals were adult (>3 months of age) pigmented C57Bl/6J mice of either sex weighing 18-33 g (Harlan Olac, Oxon, UK). Mice lacking the b2 subunit of the nicotinic acetylcholine receptor (b2À/À) were generated at the Institut Pasteur in Paris, France (Picciotto et al., 1995) , and were backcrossed for at least 12 generations onto the C57Bl/6J strain. Adult male b2À/À mice weighing 29-36 g were used. Mice were housed in single-sex groups with freely available dry food and water under a 12:12 h cycle of light and dark. All procedures were conducted under the auspices of UK Home Office Project and Personal licenses held by the authors.
Immunocytochemistry
Mice were overdosed with an intraperitoneal injection of 0.3-0.5 ml pentobarbitone sodium (SagatalÒ; 60 mg/ml;Rhô ne Mérieux Ltd., Essex, UK), then perfused transcardially with phosphate buffered saline (PBS; Sigma) followed by 4% paraformaldehyde (TAAB Laboratories, Berks, UK) in 0.1 M phosphate buffer. After post-fixing of the head for >1 week in 4% paraformaldehyde, brains were removed, sunk in 30% sucrose for cryoprotection, and sectioned coronally at 30-40 lm on a freezing microtome.
Throughout the immunocytochemical process, freefloating sections were agitated gently. Sections were initially transferred into phosphate-buffered saline (PBS) for 30 min, before incubation for 1 h at room temperature in blocking buffer consisting of 1% bovine serum albumin (Vector Laboratories, Peterborough, UK), 5% normal goat serum (NGS; Vector Laboratories, Peterborough, UK) and 0.3% Triton X-100 (Sigma) in PBS. This was followed by overnight incubation at 4°C in primary antibody solution, either 1:3000 rabbit anti-calbindin D-28k (Chemicon International, Harrow, UK), or 1:5000 rabbit anti-parvalbumin (a gift from Vivien Lane, University Laboratory of Physiology, Oxford, UK), in PBS plus 1% NGS and 0.3% Triton X-100. In 1 wild-type mouse, every section in the left hemisphere was stained for parvalbumin and every section in the right hemisphere was stained for calbindin; in 2 wildtype mice, alternate sections in both hemispheres were stained for calbindin and parvalbumin; in 5 wild-type and 8 b2À/À mice, all sections were stained for calbindin (4 wild-type bilaterally); and in 15 wild-type and 5 b2À/À mice (those that had received injections of [ 3 H] proline into the superior colliculus, see below), a 1:3 series of sections through the extent of the dLGN in one hemisphere was calbindin-stained. Control sections in each animal were incubated overnight in PBS plus 1% NGS and 0.3% Triton X-100, but minus any primary antibody. These sections never contained any labelled tissue.
After removal of the primary antibody solution and 3 · 30 min washes in PBS plus 0.3% Triton X-100, sections were incubated for 2 h at room temperature in a secondary antibody solution consisting of 1:200/500 biotinylated goat anti-rabbit IgG (Vector Laboratories, Peterborough, UK), in PBS plus 1% NGS and 0.3% Triton X-100. This was followed by another 3 · 30 min washes in PBS plus 0.3% Triton X-100, and incubation in an avidin-biotin complex solution (VectaStain Elite ABC Kit, Vector Laboratories, Peterborough, UK) for 2 h at room temperature. Then, after 5 · 30 min PBS washes, sections were reacted with diaminobenzidine (SigmaFast DAB tablets, Sigma; 0.06% nickel ammonium sulphate was added to intensify reaction product). Following a final wash in PBS, sections were mounted from distilled water onto gelatinised slides, dehydrated through graded alcohols, cleared in xylene, and coverslipped with DePeX (BDH, Dorset, UK).
All stained sections including the dLGN were inspected using a light microscope under bright field illumination. For each of these sections, a camera lucida was used to draw the outline of the dorsolateral thalamus (marked in most part by the optic tract (OT)), the outline of the dLGN, and any densely-labelled cell bodies within the dLGNÕs borders. A line parallel to and 100 lm from the ventromedial border of the optic tract was then added to each drawing, enabling a count of stained cells lying within and outside the dLGNÕs dorsolateral ÔshellÕ region. ., Co. Down, UK), administered at 2.7 ll/g. Surgical anaesthesia, defined as a complete lack of paw pinch reflex, was maintained throughout tracer injection procedures by subsequent applications of this induction dose. To prevent the accumulation of bronchial secretions, 5 ll atropine sulphate (600 lg/ml, Animalcare Ltd., Yorks; UK) was also given subcutaneously. Once the animalÕs head had been steadied in a stereotaxic frame, an incision was made over the presumptive injection site and connective tissue was cleared to reveal the skull. For injections into the far caudomedial superior colliculus (SC), a craniotomy $ 2 mm in diameter was made caudal to the lambda suture, with care taken not to damage large underlying blood vessels. For injections elsewhere in the SC, a larger craniotomy was made lateral of the midline and approximately level with the lambda suture. Cortical tissue was then aspirated to allow visualisation of the (central-lateral) SC. [ 3 H] proline solution was injected under air pressure using pipettes pulled from borosilicate glass tubing (outer diameter 0.8 mm, inner diameter 0.12 mm; Plowden and Thompson Ltd., Stourbridge, UK). Injections were made at multiple locations over the visible extent of the SC, and were aimed at superficial layers just below the pial surface. Typically, a total of 50-200 nl of tracer was injected unilaterally in 2-8 locations. After the completion of tracer injections, craniotomies were filled with absorbable haemostat material (Gelfoam Ò , Amersham
International, Bucks., UK) and/or bone wax (Ethicon, Edinburgh, UK). Where sections of skull had been removed during larger craniotomies, these were replaced and sealed with bone wax. Incisions were then securely stitched and treated with local anaesthetic cream (EMLA; Astra Pharmaceuticals Ltd., Herts, UK). Animals were left to recover in individual cages on soft bedding, with warmth provided by a closely positioned desk lamp. Occasional $ 0.15 ml subcutaneous injections of a 4% glucose, 0.18% saline solution (Aqupharm, Animalcare Ltd., York, UK) were given to aid recovery. Once post-operative mice were awake and spontaneously moving, they were placed in individual cages with freely available food and water and returned to the animal house.
Histological processing: 24-48 h after injections of [ 3 H] proline, mice were overdosed with 0.3-0.5 ml Sagatal and perfused transcardially with PBS followed by 4% paraformaldehyde in 0.1 M phosphate buffer. After a post-fixation period of >1 week in 4% paraformaldehyde in 0.1 M phosphate buffer, brains were removed, sunk in 30% sucrose and sectioned coronally at 30-40 lm on a freezing microtome. A 1:3 series of sections was stained for calbindin D-28k (see above) when it included the dLGN, and was Nissl stained when it did not. All other sections were mounted from distilled water onto gelatinised slides, and processed for autoradiography. These sections were first brought through graded alcohols to be cleared in xylene for 20 min, then returned through graded alcohols and oven dried. Under safelight illumination, slides were dipped in autoradiographic emulsion (EM-1, Amersham International, Bucks., UK) at 43°C, and air dried. They were then incubated in light-tight containers for 4 weeks at 4°C. Again under safelight illumination, these slides were developed (D19, Kodak) and fixed (Hypam Rapid Fixer, Ilford, Cheshire, UK), before (in normal light) being brought through graded alcohols, cleared once more in xylene and coverslipped with DePeX.
Quantitative analysis: After qualitative observation under dark field illumination, photographs were taken of all sections from brains injected with [ 3 H] proline that contained dense, above background anterograde label within the dLGN. Photographic negatives of the darkfield illuminated sections were then scanned and converted to 600 dpi resolution TIF images (Nikon Coolscan IV). Quantitative analysis of these images was undertaken using the ImageJ programme (http:// rsb.info.nih.gov/ij/). Measurements of mean grey value (ÔMGVÕ; i.e., image lightness) and area (ÔareaÕ) were obtained for three regions in each section: a 100 lm square region in non-visual thalamus (ÔbackgroundÕ), the dLGN as a whole (ÔdLGNÕ), and the shell region occupying the strip of tissue within 100 lm of the OTÕs ventromedial border (ÔshellÕ). These measures were used in two ways. The first, Ô%label_shellÕ, is a measure of how much of the geniculate label in a given section is located in the shell region. The second, Ôrelative densityÕ, indicates the relative intensity of the labelling within the shell. It should be noted that because of the very nonlinear relation between [
3 H] and MGV in dark-field illumination both measures will underestimate the relative strength of the projection to the shell. The Ô%label_shellÕ measure was calculated for each section, as follows:
This measure is calculated within each section, so should be less susceptible to variation between sections that might be caused by non-specific tissue, histological or photographic inconsistencies. The measure was also intended to be a close homologue of the calbindin + Ôshell %Õ measure (see Section 3)-it describes the proportion of above-background image intensity in the dLGN that is contained within the dorsolateral shell region-and should be independent of the overall strength or extent of anterograde label. A second measure, Ôrelative densityÕ, is an extension of the %label_shell measure. It simply takes a %label_shell value and divides it by the percentage of dLGN area occupied by the shell region in a given section:
This measure represents, for each section, the proportion of anterograde [ 3 H] proline label within the dLGNÕs dorsolateral shell relative to that regionÕs share of the nucleusÕ area.
Statistical procedures
All statistical analyses were carried out using parametric tests and samples were described using the mean ± SEM. All samples passed a Kolmogorov-Smirnov test for Normality, although sample sizes were probably too small (<30) for this test to be reliable. For this reason, non-parametric alternatives were also employed whenever a parametric test was used. In every case, these non-parametric tests produced identical results in terms of significance. All comparison tests were two-tailed, with the level of significance set at 0.05.
Results
Biochemical subdivision of the wild-type mouse dLGN
Immunocytochemical labelling for calcium-binding proteins shows that the unlaminated wild-type mouse dLGN can be divided into two distinct subregions. In brains stained for the presence of calbindin D-28k, the bulk of the dLGN is devoid of positively labelled cells. However, many small, densely labelled cells are present in a narrow strip of tissue on the nucleusÕ dorsolateral edge, adjacent to the optic tract ( Fig. 1(A) ). Clear localisation of calbindin-positive cells in this dorsolateral dLGN ÔshellÕ region was observed in all 23 wild-type mice whose brains were stained for the protein.
Although by no means every calbindin-positive cell in the dLGN was situated right next to the optic tract, only the odd scattered calbindin-positive cell was located in the centre of the nucleus, and positively-labelled cells close to the dLGNÕs ventromedial border were extremely rare indeed. As shown in Fig. 1(B) , localisation of calbindin-positive cells to the dorsolateral shell of the dLGN occurred throughout the nucleusÕ rostrocaudal extent. Calbindin-positive cells situated away from the optic tract were most common ventrolaterally, near the intrageniculate lamina, and were somewhat more common in caudal sections. Still, even at the far caudal pole of the dLGN, calbindin-positive cells in ventromedial portions of the nucleus were very rarely seen. Biochemical subdivision of the mouse dLGN thus appears to occur through the entire nucleus.
A simple approach was taken to quantify these observations. The ÔshellÕ of the dLGN was defined as the dorsolateral portion of the nucleus that lay within 100 lm of the optic tract ( Fig. 1(B) ). A fixed rather than a relative distance was chosen because the width of the region containing calbindin-positive cells did not appear to vary with the size of the dLGN. Indeed, if anything, calbindin-positive cells occupied a wider shell zone at the narrow caudal pole of the nucleus than at its broad rostral levels. For each section through the dLGN, the numbers of calbindin-positive cells within and outside the 100 lm shell region were counted. Within each animal, a Ôshell %Õ was then calculated as the percentage of positively labelled cells within the shell. Shell % values ranged from 74% to 92% and were tightly clustered around the mean ± SEM of 83 ± 1% (n = 23; Fig. 1(C) ). Summing cells across all animals gives a very similar result: 4123 (83%) calbindin-positive cells were situated in the dorsolateral shell region, while only 829 (17%) lay in the core of the dLGN (Fig. 1(C) inset) . The large majority of calbindin-positive cells in the wild-type mouse dLGN thus lie within 100 lm of the optic tract, subdividing the nucleus.
In contrast, immunocytochemical labelling for parvalbumin in 3 wild-type mice (5 hemispheres) failed to produce a single positively labelled cell within the dLGN. This was not due to a failure of the labelling process-as Fig. 1(D) shows, plenty of parvalbuminpositive cells were present in the hippocampus above the dLGN, and in the lateral portion of the ventral geniculate body (vLGN).
Subdivision of the wild-type mouse dLGN by the colliculogeniculate projection
If a subregion of the wild-type mouse dLGN, like the primate koniocellular dLGN, is distinguished by immunocytochemical labelling for calbindin-D28k, the same region might also mirror the primate koniocellular dLGN in being the primary focus of the colliculogeniculate projection. Anterograde neuroanatomical tracing with [
3 H] proline suggests that this is indeed the case. All injections of [ 3 H] proline into the wild-type mouse SC produced anterograde label in the dLGN that was concentrated dorsolaterally, close to the optic tract. A relatively small injection into the caudomedial pole of the SC produced highly localised anterograde label in the far lateral, rostral portion of the ipsilateral dLGNÕs shell (Fig. 2(A) ). Large proline injections into more rostral SC regions, following aspiration of the overlying cortex, also produced anterograde label concentrated in the ipsilateral dLGNÕs dorsolateral region (Fig. 2(B) and (C)). Although above-background proline terminal label was often visible throughout the ipsilateral dLGN, strong label was never seen near the nucleusÕ ventromedial border. Furthermore, in all nine wild-type animals in which SC injections were successful in producing dense anterograde label in the dLGN, this labelling was always strongest dorsolaterally, adjacent to the optic tract. Anterograde tracing with [ 3 H] proline therefore offers evidence that the wild-type mouse colliculogeniculate projection targets a restricted subregion of the dLGN. The wild-type mouse colliculogeniculate projection shows topographic ordering. As noted above, an injection into the caudomedial superficial SC produced 3 H] proline tracing of the wild-type mouse colliculogeniculate projection. Dark field photomicrographs show coronal sections of the superior colliculus (SC; 1) or dLGN (2). Injection sites in the SC are characterised by a dense core of darkly labelled cells and an outer halo of white proline label. Anterograde label in the dLGN, whose borders are marked with a dashed line, is white and particulate. The number within each dLGN photomicrograph represents the distance from the rostral pole of the dLGN, expressed as a percentage of the rostrocaudal extent of the nucleus. Numbers beneath each dLGN photomicrograph show the %label_shell and relative density measures calculated for that section (see Section 2). IC, inferior colliculus; SC, superior colliculus; LP, lateral posterior nucleus; vLGN, ventral geniculate nucleus; rd, relative density; scalebars, 500 lm. (A) Following an injection of proline into the extreme caudomedial SC (1), anterograde label is very precisely localised to the rostrolateral dLGN, and is most concentrated dorsally adjacent to the optic tract (2). (B) A large proline injection into the central-lateral portion of the SC (1) produces more widespread anterograde label in the posterior dLGN (2). This label is spread over a considerable extent of the nucleusÕ ventrolateral-dorsomedial axis, but is clearly localised in the orthogonal axis, being most concentrated dorsolaterally. Note, as in C, the dense label in LP medial to the dLGN, and in the lateral portion of the vLGN ventral to the dLGN. (C) A second large proline injection into the central-lateral SC (1) produces dLGN label that is strongest towards the caudal pole of the nucleus (2). Again, this label is concentrated most densely in the dorsolateral shell of the dLGN.
shell label in the rostrolateral dLGN ( Fig. 2(A) ). Both these sites contain representations of the temporal visual field (Wagner, McCaffery, & Drager, 2000) . More common were large injection sites concentrated in lateral portions of the superficial SC, which produced anterograde label in caudal regions of the dLGN shell ( Fig. 2(B) and (C) ). Both these sites contain representations of the ventronasal visual field (Wagner et al., 2000) .
With the intention of putting the above qualitative observations of proline labelling in the wild-type dLGN on a firmer footing, images of all sections containing dense dLGN label were analysed quantitatively. The first attempt at quantifying the pattern of anterograde proline label took the form of the Ô%label_shellÕ statistic, which was intended to represent, like the calbindin Ôshell %Õ measure described above, the proportion of radioactive proline label lying within the dorsolateral shell of the dLGN (see Section 2). The distribution of mean %la-bel_shell values for all 9 wild-type mice with dense dLGN label is shown in Fig. 3(A) . Values range from 31% to 53%, with the mean ± SEM at 41 ± 2%. These values are much lower than the calbindin shell % values in Fig. 1 ; in part, this must be a reflection of the fact that the collicular projection is strongest in the dLGN shell, but not completely restricted to that region. Inspection of the images and % values in Fig. 2 also suggests, however, that the measure might not precisely reflect the proportion of dLGN label contained in the shell region. The second section in Fig. 2A 2 , for example, has almost all its label very close to the optic tract, but receives a %label_shell value of only 47%. Thus, although the %la-bel_shell measure may reflect relative differences in the proportion of shell label across different sections, in any given single section it might not accurately represent the absolute proportion of [ 3 H] proline transported to the shell. Image mean grey values following dark-field illumination (see Section 2, Eq. (1)) do not represent an accurate, linear measure of the total amount of proline label concentrated in a particular portion of tissue.
Despite these possible drawbacks, a second measure, Ôrelative densityÕ (Section 2, Eq. (2)), shows quantitatively that the mouse colliculogeniculate projection predominantly targets the dorsolateral shell region of the dLGN. In a section with uniform label across the dLGN, this ratio should be one. When label is concentrated in the shell region, it should be greater than one. In such cases the shell contains more anterograde label than its area would predict. Fig. 3(B) shows that mean shell ratio values in all nine analysed mice were above one, with the sample mean ± SEM at 1.37 ± 0.05. So, although not quite as striking as the qualitative evidence (see Fig. 2 ), this quantitative analysis does confirm that the projection from the SC to the dLGN in the wild-type mouse predominantly targets the latterÕs dorsolateral shell region.
Biochemical and anatomical subdivision of the dLGN in b2À/À mice
Inspection of a single calbindin-labelled section from the b2À/À dLGN might lead one to infer that biochemical subdivision of the nucleus is disrupted in these mutant animals. While calbindin-positive neurons in the b2À/À dLGN, like their wild-type counterparts, were small and densely-labelled (Fig. 4(A) ), they were drastically reduced in number compared to calbindin-containing cells in normal mice. Each b2À/À dLGN section contained a mean ± SEM of only 1.7 ± 0.2 calbindinpositive neurons, a mean which was highly significantly different from the corresponding wild-type figure (11.9 ± 1.1 cells per section; t-test with Welch correction, p < 0.0001; Fig. 4(B) ). However, assessing the localisation of calbindin-containing neurons across many sections of the b2À/À dLGN (Fig. 4(C) ) revealed that, in spite of their low incidence, these neurons remained preferentially situated in the dorsolateral shell region in b2À/À mice. Over 13 b2À/À mice and 23 wild-type mice, shell % values were not significantly different (wild-type mean ± SEM: 83 ± 1%; b2À/À: 77 ± 4%; t-test with Welch correction, p = 0.1; Fig. 4(D) ). In addition, total proportions of shell-localised calbindinpositive cells across all animals did not differ significantly between the two groups (wild-type: 4123/ 4952 = 83%; b2À/À: 229/289 = 79%; v 2 test, p = 0.09). Biochemical subdivision of the b2À/À dLGN is therefore normal, despite a depleted population of calbindin-containing neurons.
The colliculogeniculate projection is also entirely normal in b2À/À mice. Large injections of [ 3 H] proline into the SC following aspiration of overlying cortex produced anterograde label in the dLGN that was strongest adjacent to the optic tract (Fig. 5(A) and (B) ). Over 9 wild-type and 5 b2À/À mice, no differences were found between either measure of this localisation (%label_ shell:wild-type mean ± SEM, 41 ± 2%; b2À/À, 43 ± 3%; t-test, p = 0.64; Fig. 5(C) ; relative density:wild-type mean ± SEM, 1.37 ± 0.05; b2À/À, 1.55 ± 0.15; t-test with Welch correction, p = 0.3; Fig.  5(D) ). The gross topography of the colliculogeniculate projection also appeared normal in b2À/À mice. Injections concentrated in the lateral SC produced label in the caudomedial dLGN, while injections covering a large mediolateral extent of the SC produced label over a large portion of the dLGNÕs mediolateral axis (see above; Wagner et al., 2000) . Shell-core lamination of the dLGN, unlike ocular lamination in the nucleus (Muir-Robinson et al., 2002; Rossi et al., 2001) , is thus largely unaffected by the b2À/À mutation.
Discussion
Our results show that the wild-type mouse dLGN can be spatially subdivided according to the biochemistry of its constituent neurons and the strength of its input from the SC. In particular, the dorsolateral ÔshellÕ of the nucleus, adjacent to the optic tract, contains the majority of the wild-type dLGNÕs calbindin-positive cells and receives the greatest density of colliculogeniculate inputs. In b2À/À mice, the dLGN is known to possess abnormal ocular ÔlaminationÕ and other organisational anomalies; nevertheless, we show that biochemical and colliculogeniculate subdivision of the nucleus is normal.
Biochemical and anatomical subdivision of the wildtype mouse dLGN-comparison with other species
In all mammalian species studied thus far, the colliculogeniculate projection subdivides the dLGN, preferentially targeting regions of the nucleus that contain the smallest neurons (Harting et al., 1991; Reese, 1984 Reese, , 1988 . Indeed, Harting et al. (1991) suggest that Ôthe distribution of tectogeniculate axons is a straightforward and simple way of identifying regions of the mammalian lateral geniculate nucleusÕ (p303). This is certainly the case in the pigmented mouse. As shown here, colliculogeniculate afferents preferentially target dorsolateral regions of the wild-type mouse dLGN, adjacent to the optic tract. In this localisation, and in its topographic precision, this projection is extremely similar to that previously described in rats (Reese, 1984) . It also closely resembles the colliculogeniculate projection pattern observed in a number of other rodent species (Harting et al., 1991) . Preferential targeting of the mouse dLGNÕs dorsolateral shell by the colliculogeniculate projection also suggests that this subregion might share homology with similar tectorecipient regions in the carnivore and primate dLGN. In monkeys and galagos, the SC targets almost exclusively the koniocellular division of the dLGN, whilst in carnivores it projects predominantly to the dLGNÕs C laminae (Harting et al., 1991) .
In its concentration of cells positive for the calciumbinding protein calbindin D-28k, the dorsolateral shell of the mouse dLGN further resembles the koniocellular dLGN of the primate. Like the koniocellular laminae in monkeys (Goodchild & Martin, 1998; Jones & Hendry, 1989) and galagos (Diamond et al., 1993; Johnson & Casagrande, 1995) , the mouse dLGNÕs dorsolateral shell contains the majority, but not quite all, of the calbindin-containing cells in the dLGN. This pattern represents the first description of the distribution of calbindin-containing cells in the rodent dLGN, although suggestive evidence from a low-resolution view of the rat dLGN (Celio, 1990) hints that similar biochemical subdivision might also occur in other rodent species. Whether mouse calbindin-containing cells resemble their primate counterparts in being glutamatergic relay neurons is, though, a question open to further investigation.
The relation between neuronal biochemistry in the dLGN and inter-species homology is complex. At one level, the mouse and primate differ from the cat in that, in the latter, calbindin-containing neurons are found in both tectorecipient C and non-tectorecipient A laminae (Demeulemeester et al., 1991) . These feline cells are also unlike primate calbindin-positive cells in that they often co-express GABA and parvalbumin (Demeulemeester et al., 1991) . Maybe one should expect closer biochemical homology between the mouse and primate dLGN than between either and the carnivore dLGN, given the far closer genetic relationship between rodents and primates compared to either with carnivores (Arnason et al., 2002) . However, this argument might not quite hold. The flying fox, proposed (though this is still debated; Ichida, Rosa, & Casagrande, 2000) to be a close relative of the primates, displays a highly unusual pattern of calbindin-positive cells in its dLGN: Neurons containing calbindin are found profusely throughout all layers of the nucleus (Ichida et al., 2000) . Closely related species, then, might not necessarily display similar patterns of calcium-binding protein expression in the dLGN. In addition, the mouse dLGN is radically different from the primate dLGN in containing absolutely no parvalbumin-positive cells. In monkeys (Goodchild & Martin, 1998; Jones & Hendry, 1989) and galagos (Diamond et al., 1993; Johnson & Casagrande, 1995) , parvalbumin is located in all non-koniocellular layers of the dLGN. In cats parvalbumin-containing cells are common in all dLGN laminae (Demeulemeester et al., 1991) . Thus, while the projection from the SC and the location of calbindin-containing cells make the dorsolateral shell of the wild-type mouse dLGN similar to the koniocellular laminae of monkeys and galagos, the lack of parvalbumin-containing cells in the rest of the mouse dLGN renders any homology with its primate nonkoniocellular counterpart partial at best.
Functional subdivision of the wild-type mouse dLGN?
As well as being anatomically and biochemically differentiated from the remainder of the wild-type mouse dLGN, is the dorsolateral shell region also functionally distinct? The results of a previous study of visual response properties in the wild-type mouse suggest not: Geniculate cells located in the dorsolateral region of the dLGN did not differ in any functional respect from cells situated in the remainder of the nucleus . It would be very surprising, though, if the biochemical and anatomical differences discovered within the wild-type mouse dLGN were not mirrored by any differences in function. After all, in almost every region of every other mammalian visual system studied thus far, structural differences are reflected in functional differentiation. It is more likely, perhaps, that the dorsolateral shell of the mouse dLGN contains some neurons that are functionally different from the rest of the neurons in that subregion, and from the remainder of cells in the dLGN as a whole. These neurons could well have been missed in the previous study . If they are similar to neurons in the tectorecipient zones of the primate (e.g., Norton & Casagrande, 1982; Xu et al., 2001 ) and cat (Sur & Sherman, 1982) dLGN, functionally distinct cells in the mouse dLGNÕs dorsolateral shell will be small, and will respond weakly and sluggishly to visual stimulation. These cellsÕ action potentials might therefore be biased against by the tungsten recording electrodes employed in the previous study So & Shapley, 1979) , while their visual responses might have been overlooked in favour of more reliably and briskly firing neurons. Indeed, these are presumably some of the reasons why the primate koniocellular pathway was overlooked for so long (Casagrande, 1994) . Perhaps future investigations employing more systematic sampling techniques, stimulation of the SC, and/or intracellular recording followed by cell filling and immunocytochemical staining, will uncover a distinct functional subpopulation of mouse dLGN neurons that has so far been overlooked.
Normal biochemical and anatomical subdivision of the b2À/À dLGN
Despite the disruption of ocular ÔlaminationÕ (MuirRobinson et al., 2002; Rossi et al., 2001 ) and other aspects of organisation in the b2À/À dLGN, the subdivision of the nucleus by collicular afferents and calbindin-positive neurons is entirely normal. The formation of eye-specific regions (Muir-Robinson et al., 2002; Rossi et al., 2001) , fine retinotopy , and On-Off cell arrangements in the dLGN can therefore be completely independent of the formation of other biochemical and anatomical geniculate subdivisions. Our data also demonstrate that normal biochemical and colliculogeniculate subdivision of the dLGN is entirely independent of transmission through b2-subunit-containing nAChRs anywhere in the brain and at any point in development. Furthermore, since the developmental effects of the b2À/À mutation on geniculate organisation are believed to stem from abnormalities in the patterning of spontaneous activity in the early postnatal retina (McLaughlin et al., 2003) , our data show that subdivision of the dLGN by collicular afferents and calbindin-containing neurons is not influenced by patterns of spontaneous firing in neonatal retinal ganglion cells.
These results might have been predicted by developmental studies in the cat. Subdivision of the cat dLGN by the colliculogeniculate projection depends on an intact retinal projection (Sutton & Brunso-Bechtold, 1988 ), but occurs extremely late in postnatal development, at a time when eye-specific laminae have already formed (Stein, McHaffie, Harting, Huerta, & Hashikawa, 1985) . Since the retinal effects of the b2À/À mutation occur primarily in early postnatal life (Bansal et al., 2000; McLaughlin et al., 2003; Muir-Robinson et al., 2002) , it might not, therefore, be too surprising that the colliculogeniculate projection is normal in b2À/À mice. Nevertheless, it is still striking that this projection can target appropriate regions of the dLGN even when other organisational features of the nucleus have already been profoundly disrupted.
Finally, the reduced number of calbindin-positive cells in the b2À/À dLGN is striking: WT mice have approximately seven times as many calbindin-positive cells as b2À/À mice. Although we have not measured neuronal density in WT and b2À/À dLGN, it seems very unlikely that the reduction is explained simply by a change in neuronal density in the b2À/À LGN. Because of their low incidence even in the WT dLGN, neuronal density measures are also unlikely to reveal whether there is a loss of calbindin staining or a loss of neurons that express calbindin. The mechanism for the selective loss of calbindin labelling can only be guessed at. It could be a consequence of perturbed retinal activity, or it could arise from altered thalamic cholinergic modulation. We note one important implication of this result, however: Although calbindin-containing cells and the colliculogeniculate projection are always most concentrated in the dorsolateral shell of the mouse dLGN, the fact that calbindin-positive cells can be drastically reduced in number without affecting the localisation of colliculogeniculate afferents suggests these two geniculate-subdividing features are not totally interdependent.
